Democratic Progressive Party Legislator Huang Sue-ying (
Research results released last month by the US Food and Drug Administration (FDA) showed that women taking new diabetes medicine containing rosiglitazone and pioglitazone were more likely to suffer from fractures than men taking the same drugs, Huang told a press conference.
As for women who take new contraceptive drugs containing desogestrel are twice as likely to suffer from blood clots than women who take other types of contraceptives, she said.
Drugs containing rosiglitazone and pioglitazone used to treat diabetes in the country include Avandia and Actos, while contraceptive drugs containing desogestrel include Ethistrel Tablet, Marvelon Tablet and Mercilon Tablet, Huang said.
no action taken
"These research results have been publicized on the FDA's Web site since February, but the DOH failed to take any action all this time," Huang said.
"It only issued an alert on Monday after we informed the Bureau of Pharmaceutical Affairs that we were going to hold a press conference about this," she said.
"DOH, as the government agency in charge [of pharmaceutical affairs], does not have enough awareness," she said, accusing the health department of failing to follow the effects of new drugs after they enter the market.
responsibilities
She demanded that the department carry out its responsibility of supervising the safety of medication and informing all doctors, pharmacists and patients of potential health risks from new medication as soon as studies or results come out.
Bureau director Liao Chi-chou (廖繼洲), who was also present at the conference, said that the health department has initiated projects to monitor the side effects of the new drugs, but has not received reports of fractures among women taking the new medicine to treat diabetes.
Liao said that the bureau would continue to keep a close eye on any new information about the side effects of new medicines on the FDA's Web site.
Alain Robert, known as the "French Spider-Man," praised Alex Honnold as exceptionally well-prepared after the US climber completed a free solo ascent of Taipei 101 yesterday. Robert said Honnold's ascent of the 508m-tall skyscraper in just more than one-and-a-half hours without using safety ropes or equipment was a remarkable achievement. "This is my life," he said in an interview conducted in French, adding that he liked the feeling of being "on the edge of danger." The 63-year-old Frenchman climbed Taipei 101 using ropes in December 2004, taking about four hours to reach the top. On a one-to-10 scale of difficulty, Robert said Taipei 101
Nipah virus infection is to be officially listed as a category 5 notifiable infectious disease in Taiwan in March, while clinical treatment guidelines are being formulated, the Centers for Disease Control (CDC) said yesterday. With Nipah infections being reported in other countries and considering its relatively high fatality rate, the centers on Jan. 16 announced that it would be listed as a notifiable infectious disease to bolster the nation’s systematic early warning system and increase public awareness, the CDC said. Bangladesh reported four fatal cases last year in separate districts, with three linked to raw date palm sap consumption, CDC Epidemic Intelligence
US climber Alex Honnold left Taiwan this morning a day after completing a free-solo ascent of Taipei 101, a feat that drew cheers from onlookers and gained widespread international attention. Honnold yesterday scaled the 101-story skyscraper without a rope or safety harness. The climb — the highest urban free-solo ascent ever attempted — took just more than 90 minutes and was streamed live on Netflix. It was covered by major international news outlets including CNN, the New York Times, the Guardian and the Wall Street Journal. As Honnold prepared to leave Taiwan today, he attracted a crowd when he and his wife, Sanni,
Taiwanese and US defense groups are collaborating to introduce deployable, semi-autonomous manufacturing systems for drones and components in a boost to the nation’s supply chain resilience. Taiwan’s G-Tech Optroelectronics Corp subsidiary GTOC and the US’ Aerkomm Inc on Friday announced an agreement with fellow US-based Firestorm Lab to adopt the latter’s xCell, a technology featuring 3D printers fitted in 6.1m container units. The systems enable aerial platforms and parts to be produced in high volumes from dispersed nodes capable of rapid redeployment, to minimize the risk of enemy strikes and to meet field requirements, they said. Firestorm chief technology officer Ian Muceus said
RSS